RJA
ZBH icon

Ross\Johnson & Associates’s Zimmer Biomet ZBH Stock Holding History

Ross\Johnson & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Hold
55
– – 0.07% 49
2026
Q1 		$4.97K Sell
55
-1
-2% -$92 0.09% 49
2025
Q4 		$5.04K Buy
56
+1
+2% +$95 0.09% 50
2025
Q3 		$5.42K Hold
55
– – 0.1% 47
2025
Q2 		$5.02K Hold
55
– – 0.1% 44
2025
Q1 		$6.22K Hold
55
– – 0.11% 74
2024
Q4 		$5.81K Buy
+55
New +$5.9K 0.13% 40

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ross\Johnson & Associates's ZBH Position: Q2 2026 in Review

Ross\Johnson & Associates held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 55 shares worth $4.74K. The position accounts for 0.07% of the portfolio, ranked #49.

Ross\Johnson & Associates first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.22K in Q1 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ross\Johnson & Associates held 55 shares of Zimmer Biomet worth $4.74K as of Q2 2026.
  • Ross\Johnson & Associates left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.07% of Ross\Johnson & Associates's portfolio in Q2 2026, its #49 holding.
  • Ross\Johnson & Associates first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Zimmer Biomet position peaked at $6.22K in Q1 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.